Personalised insoles via additive manufacture for the prevention of plantar ulceration in diabetes

Informations projet

D-FOOTPRINT

N° de convention de subvention: 329133

Projet clôturé

Date de début 14 Octobre 2013

Date de fin 13 Octobre 2015

Financé au titre de

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Coût total € 196 682,10

Contribution de l’UE € 196 682,10

Coordonné par

THE GLASGOW CALEDONIAN UNIVERSITY
Royaume-Uni

Objectif

Foot ulceration in patients with diabetes remains a highly prevalent, debilitating and expensive to treat problem. Recent recommendations by the International Working Group on the Diabetic Foot have suggested that therapeutic footwear including a custom insole should be the preferred intervention for those individuals who have been identified as “at risk” of developing a foot ulcer [1]. However, current methods for the design and fabrication of custom insoles limit the potential to incorporate innovations that could increase the effectiveness of these devices, primarily due to the geometric restrictions inherent to the methods.

The overall aim of this 24 month project is to develop, evaluate and disseminate a novel prescription paradigm, focused on additive manufacturing (AM) and biomechanical modelling enabled design rules, for insoles aimed at preventing or treating plantar surface ulceration in the diabetic foot. To achieve this, the latest biomechanical modelling approaches will be combined with AM technologies to develop novel prototype orthotic devices which are personalised to maximise benefit to the patient. A thorough program of pre-clinical and clinical evaluation will be established to test these devices, focused on assessing biomechanical and short term patient reported outcomes. This work program builds upon the successful research and technology developments in the EC-funded A-FOOTPRINT project (Grant Agreement no.: NMP2-SE-2009-228893), advancing integration of AM into the orthotic prescription process to a new and previously untried but highly relevant disease group.

The research will result in 1) a fundamental paradigm shift from subtraction (milling) to additive manufacturing, 2) step-change advances in personalised orthotic design optimisation, and 3) a new therapeutic option for a debilitating and expensive European and worldwide health problem

Champ scientifique (EuroSciVoc)

CORDIS classe les projets avec EuroSciVoc, une taxonomie multilingue des domaines scientifiques, grâce à un processus semi-automatique basé sur des techniques TLN. Voir: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• sciences médicales et de la santé › médecine clinique › endocrinologie › diabète
• ingénierie et technologie › génie mécanique › ingénierie de fabrication › fabrication additive

Vous devez vous identifier ou vous inscrire pour utiliser cette fonction

Programme(s)

• FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Thème(s)

• FP7-PEOPLE-2012-IOF - Marie Curie Action: "International Outgoing Fellowships for Career Development"

Appel à propositions

FP7-PEOPLE-2012-IOF
Voir d’autres projets de cet appel

Régime de financement

MC-IOF -

Coordinateur

THE GLASGOW CALEDONIAN UNIVERSITY

• Contribution de l’UE: € 196 682,10
• Adresse: Cowcaddens Road, City Campus 70 ; G4 0BA Glasgow ; Royaume-Uni
• Type d’activité: Établissements d’enseignement supérieur ou secondaire
• Coût total: Aucune donnée